indusatumab vedotin antibodydrug conjugate development treatment pancreatic gastrointestinal consists monoclonal antibody indusatumab targets enzyme guanylate cyclase present cancers linked average three four molecules chemotherapeutic agent monomethyl auristatin e phase ii clinical trials february trials terminated insufficient antineoplastic immunomodulatory drug article stub help wikipedia expanding monoclonal article stub help wikipedia expanding httpsenwikipediaorgwikiindusatumabvedotin